JP2013511496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511496A5 JP2013511496A5 JP2012539355A JP2012539355A JP2013511496A5 JP 2013511496 A5 JP2013511496 A5 JP 2013511496A5 JP 2012539355 A JP2012539355 A JP 2012539355A JP 2012539355 A JP2012539355 A JP 2012539355A JP 2013511496 A5 JP2013511496 A5 JP 2013511496A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- carbon atoms
- dosage form
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 150000002430 hydrocarbons Chemical group 0.000 claims 3
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 claims 3
- 229960004134 propofol Drugs 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 206010002091 Anaesthesia Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010039897 Sedation Diseases 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000037005 anaesthesia Effects 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 230000004112 neuroprotection Effects 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 230000036280 sedation Effects 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014548A EP2332525A1 (en) | 2009-11-23 | 2009-11-23 | Pharmaceutical composition comprising propofol |
| EP09014548.3 | 2009-11-23 | ||
| PCT/EP2010/067938 WO2011061332A1 (en) | 2009-11-23 | 2010-11-22 | Pharmaceutical composition comprising propofol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013511496A JP2013511496A (ja) | 2013-04-04 |
| JP2013511496A5 true JP2013511496A5 (https=) | 2013-12-05 |
| JP5707009B2 JP5707009B2 (ja) | 2015-04-22 |
Family
ID=41694756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012539355A Active JP5707009B2 (ja) | 2009-11-23 | 2010-11-22 | プロポフォールを含有する医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8796340B2 (https=) |
| EP (2) | EP2332525A1 (https=) |
| JP (1) | JP5707009B2 (https=) |
| KR (1) | KR20120104262A (https=) |
| CN (1) | CN102753159B (https=) |
| AU (1) | AU2010320823B2 (https=) |
| BR (1) | BR112012012108A2 (https=) |
| CA (1) | CA2776855C (https=) |
| ES (1) | ES2450423T3 (https=) |
| IN (1) | IN2012DN03130A (https=) |
| MX (1) | MX2012005881A (https=) |
| WO (1) | WO2011061332A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2547323T3 (pl) | 2010-03-17 | 2016-07-29 | Novaliq Gmbh | Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| DK2714010T3 (en) | 2011-05-25 | 2017-06-12 | Novaliq Gmbh | TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES |
| JP6023181B2 (ja) | 2011-05-25 | 2016-11-09 | ノバリック ゲーエムベーハー | 爪に投与するための医薬組成物 |
| GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
| KR101989648B1 (ko) | 2012-01-23 | 2019-06-14 | 노바리크 게엠베하 | 부분불소화 알칸에 기초한 안정화된 단백질 조성물 |
| AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
| CN113679699B (zh) | 2012-09-12 | 2022-10-28 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| DK2708228T3 (en) * | 2012-09-12 | 2018-08-20 | Novaliq Gmbh | COMPOSITION FOR EYE RINSE |
| PT3024484T (pt) | 2013-07-23 | 2018-10-24 | Novaliq Gmbh | Composições de anticorpo estabilizadas |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| US20180022698A1 (en) | 2014-10-16 | 2018-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Novel methods, compounds, and compositions for anesthesia |
| US11154513B2 (en) | 2015-09-30 | 2021-10-26 | Novaliq Gmbh | Semifluorinated compounds |
| CN110403923B (zh) | 2015-09-30 | 2021-09-21 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| PT3442480T (pt) | 2016-06-23 | 2019-12-23 | Novaliq Gmbh | Método de administração tópica |
| CA3036297C (en) | 2016-09-22 | 2023-09-05 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| WO2018055101A1 (en) | 2016-09-23 | 2018-03-29 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| EP4374851B1 (en) | 2016-12-23 | 2026-04-15 | Novaliq GmbH | Ophthalmic composition for treatment of dry eye disease |
| CA3058097C (en) | 2017-04-21 | 2024-01-02 | Novaliq Gmbh | Iodine compositions |
| US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
| MX2020003534A (es) | 2017-09-27 | 2020-07-29 | Novaliq Gmbh | Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares. |
| WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
| KR20200128407A (ko) | 2018-03-02 | 2020-11-12 | 노바리크 게엠베하 | 네비볼롤을 포함하는 약제학적 조성물 |
| SG11202007860XA (en) | 2018-03-28 | 2020-09-29 | Novaliq Gmbh | Pharmaceutical composition comprising timolol |
| CN112153970A (zh) | 2018-04-27 | 2020-12-29 | 诺瓦利克有限责任公司 | 用于治疗青光眼的包含他氟前列素的眼用组合物 |
| EP3856124A1 (en) | 2018-09-27 | 2021-08-04 | Novaliq GmbH | Lipid barrier repair |
| SG11202102820VA (en) | 2018-10-12 | 2021-04-29 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| EP3923907B1 (en) | 2019-02-13 | 2024-09-25 | Novaliq GmbH | Compositions and methods for the treatment of ocular neovascularization |
| KR20220058577A (ko) | 2019-09-06 | 2022-05-09 | 노바리크 게엠베하 | 포도막염 치료를 위한 안과용 조성물 |
| EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
| DE19536504C2 (de) | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| EP1124416A1 (en) * | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
| CA2549524A1 (en) * | 2004-01-02 | 2005-07-28 | Wisconsin Alumni Research Foundation | Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| DE102004030044A1 (de) | 2004-06-22 | 2006-01-12 | Birken Gmbh | Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels |
| EP2099408B1 (en) * | 2006-11-28 | 2016-10-05 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| ES2377152T3 (es) * | 2008-04-18 | 2012-03-22 | Novaliq Gmbh | Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar |
-
2009
- 2009-11-23 EP EP09014548A patent/EP2332525A1/en not_active Withdrawn
-
2010
- 2010-11-22 BR BR112012012108A patent/BR112012012108A2/pt not_active Application Discontinuation
- 2010-11-22 ES ES10778677.4T patent/ES2450423T3/es active Active
- 2010-11-22 JP JP2012539355A patent/JP5707009B2/ja active Active
- 2010-11-22 US US13/511,184 patent/US8796340B2/en active Active
- 2010-11-22 AU AU2010320823A patent/AU2010320823B2/en active Active
- 2010-11-22 KR KR1020127016348A patent/KR20120104262A/ko not_active Withdrawn
- 2010-11-22 CN CN201080052400.7A patent/CN102753159B/zh active Active
- 2010-11-22 MX MX2012005881A patent/MX2012005881A/es not_active Application Discontinuation
- 2010-11-22 EP EP10778677.4A patent/EP2503999B1/en active Active
- 2010-11-22 IN IN3130DEN2012 patent/IN2012DN03130A/en unknown
- 2010-11-22 WO PCT/EP2010/067938 patent/WO2011061332A1/en not_active Ceased
- 2010-11-22 CA CA2776855A patent/CA2776855C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013511496A5 (https=) | ||
| ES2894836T3 (es) | Compuestos de CBD fluorados, composiciones y usos de los mismos | |
| RU2009111388A (ru) | Органические соединения | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2022180461A5 (https=) | ||
| JP2013509429A5 (https=) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| JP2011500781A5 (https=) | ||
| JP2013513586A5 (https=) | ||
| JP2015529229A5 (https=) | ||
| EA201500293A1 (ru) | Антихолинэргическая нейропротективная композиция и способы | |
| RU2018135967A (ru) | Интраназальные фармацевтические композиции на основе бензодиазепина | |
| PE20091672A1 (es) | Nueva dosificacion y formulacion | |
| BR112014029735A2 (pt) | forma de dosagem e formulação de abediterol | |
| RU2015136849A (ru) | Композиции, содержащие 15-он эпк, и способы их применения | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2014515407A5 (https=) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei | |
| JP2015509075A5 (https=) | ||
| AR087868A1 (es) | Compuestos de triazolopiridina como moduladores de la tirosina quinasa c-met | |
| RU2008124825A (ru) | Органические соединения, включающие соль гликопиррония | |
| EP2476429A4 (en) | PTH-CONTAINING THERAPY / PROPHYLAXIS AGENT FOR OSTEOPOROSIS ONCE PER WEEK, WITH ONE UNIT DOSE OF 100 TO 200 UNITS OF SUCCESSFUL PTH ADMINISTRATION | |
| JP2015502371A5 (https=) | ||
| JP2014511897A5 (https=) | ||
| WO2015009731A3 (en) | Azacyclic constrained analogs of fty720 |